Skip to main content

Clinical Decision Support System (CDSS) Market by Manufacturers, Key Development Strategies and Forecasts to 2020

Clinical decision support systems are versatile, which has spurred adoption among healthcare organizations. The rise in the number of hospitals, surging cases of medical emergency, and the rise in geriatric population are key factors boosting the growth of the market.
Market Overview
Clinical Decision Support Systems are computerized systems, which are designed to provide deep-diving insights to healthcare professionals to aid in numerous decision-making activities. Such systems include a variable cast of devices and vary according to the nature of the diseases being treated. In recent years, clinical decision support systems have become a valuable guidance tool for the healthcare industry.
The Clinical Decision Support System (CDSS) Market, as per Market Research Future (MRFR), in its latest report, is likely to expand at CAGR of 12% to reach a valuation of USD 1.76 Bn by the end of the assessment period of 2018-2023.
However, such systems run the risk of data breach, which can be disruptive to the growth of the market. Meanwhile, the market is likely to benefit from the shift of the healthcare sector towards data-driven technologies, and the advent of healthcare technologies such as healthcare AI, EMRs, and other healthcare technologies.
Competitive Landscape
Product launches and investment in R&D are a few of the important strategies employed by the top players in the global market to facilitate growth.
Hearst Health, Allscripts, Agfa-Gevaert Group, Wolters Kluwer Health, Athenahealth, Inc, Elsevier B.V., Meditech, Cerner Corporation, Epic Systems Corporation, and Carestream are the key players in the clinical decision support system market.
Segmentation
The global clinical decision support systems market has been segmented based on component, product type, model, delivery mode, mode of advice, setting, type, and application.
By component, the clinical decision support systems market has been segmented into software, hardware, and services. The software segment held the largest share of the market and stood at USD 493.43 Mn in 2017. The software segment is anticipated to reach USD 982.42 Mn by the end of 2023.
By product, the clinical decision support systems market has been segmented into integrated and standalone variants. The integrated CDSS segment accounts for the larger share of the global market and is anticipated to capture the highest CAGR as well. Integrated CDSS allows healthcare professionals to share a common interface and database, thus, simplifying processes.
By model, the clinical decision support systems market has been segmented into knowledge-based and non-knowledge-based CDSS. The knowledge-based CDSS segment has the upper hand in the market. These systems aid in decision making in uncertain conditions and are easy to access.
By delivery mode, the clinical decision support systems market has been segmented into cloud and on-premise.
By mode of advice, the clinical decision support systems market has been segmented into active and passive. With almost 75% share of the market, the active CDSS segment is domineering the global market.
By setting, the clinical decision support systems market has been segmented into inpatient settings and ambulatory care. The inpatient setting segment accounts for the majority share of 70% of the global market.
By type, the clinical decision support systems market has been segmented into therapeutic and diagnostic CDSS.
By application, the clinical decision support systems market has been segmented into advanced and conventional CDSS.
Intended Audience
  • Medical Devices Companies
  • Research and Development (R&D) Companies
  • Government Research Institutes
  • Academic Institutes and Universities
Browse the market data and in-depth information of this Report at: https://www.marketresearchfuture.com/reports/clinical-decision-support-systems-market-6038
Regional Analysis
Region-wise, the clinical decision support market has been segmented into North America, Asia Pacific (APAC), the Middle East & Africa (MEA), Latin America, and Europe.
North America holds the largest share of the global clinical decision support systems market. The existence of major key players in the region gives leverage over others. Moreover, the advanced state of healthcare in the region and high expenditure on healthcare are furthering the growth of the market.
Europe accounts for an advantageous share of the global market and is likely to exhibit rapid growth over the forecast period. Government initiative undertaken to improve the healthcare sector, accessibility of advanced healthcare facilities, and increasing healthcare expenditure is some of the factors driving the growth of the Europe market.
Relentless strides made by the government of the emerging economies of APAC towards the modernization of the healthcare sector is likely to fuel the growth of the APAC market.
Market Growth Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Investment Opportunity Analysis
5.3 Value Chain Analysis
5.3.1 Inputs
…To be Continued
About Market Research Future:
Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Phone: +16468459312
Labels:

Comments

Post a Comment

Popular posts from this blog

hyperpigmentation disorders treatment Overview

hyperpigmentation disorders treatment Analysis Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. The global hyperpigmentation disorders treatment Market was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period. Browse Complete Premium Research Report Enabled with Respective Tables and Figures at  https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462 Segmentation of The global h yperpigmentation disorders treatment market Segments  has been segmented based on treatment type, dise...
Post a Comment
Read more

Laminated Glass Market Rising Trends, Global Opportunity, demand Analysis and Precise Industry Outlook

Laminated Glass Market Research Overview 2021-2026: Laminated Glass Growth Analysis by Key Players, Types, Applications, Countries, and Forecast. This Laminated Glass research report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. The Research study also analyses key emerging trends and their impact on present and future development. The process has significantly miniaturized various tools that creates more opportunities for the Laminated Glass section to penetrate the growth is valued at xx million US$ in 2020 and is expected to reach xx million US$ by the end of 2026, at a growing CAGR of xx%. Inquire for Free Sample Pages before Purchase of this Research Report: https://www.industrydataanalytics.com/reports/global-laminated-glass-market/inquiry?Mode=rohit The Laminated Glass Market Dynamics Majorly Targeted the Restraints Factors, Growth Opportunities and Future Challenges d...
Post a Comment
Read more

Newer Technology in Dupuytren’s contracture Market Treatment and Diagnosis Overview

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market is expected to reach USD 5.5 billion ...
Post a Comment
Read more